FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy
The FDA has required and approved safety labeling changes to the Prescribing Information for the following RSV vaccines:
- Abrysvo (Respiratory Syncytial Virus Vaccine) manufactured by Pfizer Inc.
- Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) manufactured by GlaxoSmithKline Biologicals
Read more.
